Top 5 Defensive Stocks Which Could Rescue Your Portfolio For July
Portfolio Pulse from Lisa Levin
The article lists five oversold stocks in the consumer staples sector that could be potential investment opportunities. These include The Estée Lauder Companies Inc. (EL), Smart for Life, Inc. (SMFL), ZIVO Bioscience, Inc. (ZIVO), BRC Inc. (BRCC), and AppHarvest, Inc. (APPH). The stocks are considered oversold as their Relative Strength Index (RSI) is near or below 30. The companies have experienced various events such as price target downgrades, compliance with Nasdaq listing requirements, direct offerings, better-than-expected sales, and Chapter 11 filings.

July 25, 2023 | 11:29 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Smart for Life regained compliance with Nasdaq listing requirements. The stock fell 1.5% to close at $0.6410 on Monday.
Regaining compliance with Nasdaq listing requirements is a positive sign, but the stock still fell, indicating mixed market sentiment.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
AppHarvest announced a Chapter 11 filing to support a financial and operational transition. The stock fell 73.1% to close at $0.09 on Monday.
The announcement of a Chapter 11 filing indicates financial distress, which could significantly decrease investor confidence and lead to a drop in the stock price.
CONFIDENCE 95
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
BRC Inc. reported better-than-expected quarterly sales but the stock fell 5.7% to close at $4.64 on Monday.
Despite reporting better-than-expected sales, the stock price fell, indicating that other factors may be influencing investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Estée Lauder's stock was downgraded by Piper Sandler and Raymond James, with lowered price targets. The stock fell 1.5% to close at $177.04 on Monday.
The downgrades and lowered price targets by Piper Sandler and Raymond James could negatively impact investor sentiment, potentially leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
ZIVO Bioscience announced a $4 million registered direct offering. The stock fell 2.7% to close at $1.81 on Monday.
The announcement of a direct offering could dilute existing shares, potentially leading to a decrease in the stock price.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 100